The Potential Value of Immunohistochemistry as a Screening Tool for Oncogenic Targets of Personalized Lung Cancer Therapy

Author： Ilie Marius   Hofman Paul  

Publisher： Optimal Clinical Ltd

E-ISSN： 2052-5931|1|1|82-92

ISSN： 2053-2091

Source： The Journal of OncoPathology, Vol.1, Iss.1, 2013-04, pp. : 82-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 6, 2007-11 ,pp. : 594-611

Bentham Science Publishers

Access to resources Recommend Favorite

Depression in lung cancer patients: is the HADS an effective screening tool?

By Castelli Lorys   Binaschi Luca   Caldera Paola   Torta Riccardo  

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1129-1132

Springer Publishing Company

Access to resources Recommend Favorite

Pathology and personalized medicine in lung cancer

By Kerr Keith M   Loo Peh Sun   Nicolson Marianne C  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 35-46

Future Medicine

Access to resources Recommend Favorite

Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy

By Zhang Jiao   Chen Yan-Hua   Lu Qun  

Future Oncology, Vol. 6, Iss. 4, 2010-04 ,pp. : 587-603

Future Medicine

Access to resources Recommend Favorite

Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite